Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1α (MIP-1α), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD)

Clinical and Experimental Immunology

Volumn 117, Issue 2, 1999, Pages 237-243

  Hatano, Yutaka ^a   Katagiri, K ^a   Takayasu, S ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; IL 8 macrophage inflammatory protein 1 ; RANTES mononuclear cells

Indexed keywords

CHEMOKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; RANTES;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHILIA; FEMALE; HUMAN; LEUKOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PSORIASIS VULGARIS; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; AGED; DERMATITIS, ATOPIC; EOSINOPHILIA; FEMALE; HUMANS; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; PSORIASIS; RANTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN DISEASES;

EID: 0032839032     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00982.x     Document Type: Article

References (38)

1. 1 Alam R. Chemokines in allergic inflammation. J Allergy Clin Immunol 1997; 99:273-7.
2. 2 Michel G, Mirmohammadsadegh A, Olasz E et al. Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes. J Immunol 1997; 159:6291-7.
3. 3 Szabo MC, Butcher EC, McIntyre BW et al. RANTES stimulation of T lymphocyte adhesion and activation: role for LFA-1 and ICAM-3. Eur J Immunol 1997; 27:1061-8.
4. 4 Karpus WJ, Lukacs NW, Kennedy KJ et al. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 1997; 158:4129-36.
5. 5 Schröder J-M. Cytokine networks in the skin. J Invest Dermatol 1995; 105:20S-24S.
6. 6 Noso N, Sticherling M, Bartels J et al. Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts. J Immunol 1996; 156:1946-53.
7. 7 Fukuoka M, Ogino Y, Sato H et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 1998; 138:63-70.
8. 8 Hsieh K-H, Chou CC, Chiang BL. Immunotherapy suppresses the production of monocyte chemotactic and activating factor and augments the production of IL-8 in children with asthma. J Allergy Clin Immunol 1996; 98:580-7.
9. 9 Kimata H, Lindley I. Detection of plasma interleukin-8 in atopic dermatitis. Arch Dis Child 1994; 70:119-22.
10. 10 Yamada H, Izutani R, Chihara J et al. RANTES mRNA expression in skin and colon of patients with atopic dermatitis. Int Arch Allergy Immunol 1996; 1:19-21.
11. 11 Ying S, Taborda BL, Meng Q et al. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med 1995; 181:2153-9.
12. 12 Schroder JM, Noso N, Sticherling M, Christophers E. Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. J Leukocyte Biol 1996; 59:1-5.
13. 13 Teranishi Y, Mizutani H, Murata M, Shimizu M, Matsushima K. Increased spontaneous production of IL-8 in peripheral blood monocytes from the psoriatic patient: relation to focal infection and response to treatments. J Dermatol Sci 1994; 10:8-15.
14. 14 Okubo Y, Koga M. Peripheral blood monocytes in psoriatic patients overproduce cytokines. J Dermatol Sci 1998; 17:223-32.
15. 15 Bruch-Gerharz D, Fehsel K, Suschek C et al. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 1996; 184:2007-12.
16. 16 Schmidt E, Ambach A, Bastian B et al. Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects. J Am Acad Dermatol 1996; 34:310-2.
17. 17 Inaoki M, Takehara K. Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid. J Dermatol Sci 1998; 16:152-7.
18. 18 Katagiri K, Itami S, Hatano Y, Takayasu S. Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis (AD). Clin Exp Immunol 1997; 108:289-94.
19. 19 Katagiri K, Itami S, Hatano Y et al. In vivo expression of IL-4, IL-5, IL-13, and IFN-γ mRNA in peripheral blood mononuclear cells and effect of cyclosporin A in a patient with Kimura's disease. Br J Dermatol 1997; 137:972-7.
20. 20 Uyemura K, Yamamura M, Fivenson DF et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993; 101:701-5.
21. 21 Schlaak JF, Buslau M, Jochum W et al. T cells involved in psoriasis vulgaris belong to the Th 1 subset. J Invest Dermatol 1994; 102:145-9.
22. 22 Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980; 92:44-47.
23. 23 Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 1989; 144:13-14.
24. 24 Chomezynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
25. 25 Schrum S, Probst P, Fleischer B, Zipfel PF. Synthesis of the CC-chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 immune response. J Immunol 1996; 157:3598-604.
26. 2 type T-cell clone during the induction phase of anergy. Clin Exp Allergy 1996; 26:20-27.
27. 27 Mauri-Hellweg D, Bettens F, Mauri D et al. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995; 155:462-72.
28. 28 Kodama N, Yamaguchi E, Hizawa N et al. Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases. Am J Respir Cell Mol Biol 1998; 18:526-31.
29. 29 Schall TJ, Jongstra J, Dyer BJ et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988; 141:1018-25.
30. 30 Klouche M, Klinger MH, Kuhnel W, Wilhelm D. Endocytosis, storage, and release of IgE by human platelets: differences in patients with type 1 allergy and nonatopic subjects. J Allergy Clin Immunol 1997; 100:235-41.
31. 31 Chihara J, Yasuba H, Tsuda A, Urayama O, Saito N, Honda K. Elevation of the plasma level of RANTES during asthma attacks. J Allergy Clin Immunol 1997; 100:S52-55.
32. 32 Goebeler M, Yoshimura T, Toksoy A et al. The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J Invest Dermatol 1997; 108:445-51.
33. 33 Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991; 3:165-83.
34. 34 Nelson PJ, Kim HT, Manning WC et al. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 1993; 151:2601-12.
35. 35 Adcock IM, Lane SJ, Brown CR et al. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 1995; 154:3500-5.
36. 36 Berkman N, Jose PJ, Williams TJ et al. Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages. Am J Phys 1995; 269:L443-52.
37. 37 Marfaing KA, Maravic M, Humbert M et al. Contrasting effects of IL-4, IL-10 and corticosteroids on RANTES production by human monocytes. Int Immunol 1996; 8:1587-94.
38. 38 Wingett D, Forcier K, Nielson CP. Glucocorticoid-mediated inhibition of RANTES expression in human T lymphocytes. FEBS Letters 1996; 398:308-11.